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Abstract: Radiation therapy is considered to be one of important treatment protocols for cancers.
Radiation therapy employs several beams of ionizing radiation to kill cancer tumors, but such
irradiation also causes damage to normal tissues. Therefore, a treatment plan should satisfy
dose-volume constraints (DVCs). Intensity-modulated radiotherapy treatment (IMRT) enables to
control the beam intensities and gives more flexibility for the treatment plan to satisfy the DVCs.
Romeijn et al. [Physics in Medicine and Biology, 48(21):3521, 2003] replaced the DVCs in an IMRT
optimization with C-VaR (Conditional Value-at-Risk) type constraints, and proposed a numerical
method based on linear programming (LP). Their approach reduced the computation cost of the
original DVCs, but the feasible region of their LP problems was much narrow compared to the
DVCs, therefore, their approach often failed to find a feasible plan even when the DVCs were not
so tight.
In this paper, we propose a successive LP approach with the C-VaR type constraints. We
detect outliers form the solution of LP problems, and remove them from the domain of the C-
VaR type constraints. This eases the sensitivity of C-VaR type constraints to outliers and we can
search feasible plans from wider regions. Furthermore, we can give a mathematical proof that if
the optimal value of the LP problem in the proposed approach is non-positive, the corresponding
optimal solution satisfies all the DVCs. From numerical experiments on test data sets, we observed
that our approach found feasible solutions more appropriately than existing LP approaches. In
addition, our approach required fewer LP problems, and this led to a short computation time.
Keywords: Intensity-modulated radiotherapy treatment, Fluence map optimization, Linear pro-
gramming, C-VaR
1 Introduction
In many countries, cancer is considered to be one of the principal causes of death. In Japan, it
was reported in [15] that the fatalities number rose to 350 thousand people and 800 thousand
people were newly diagnosed as cancer in the year 2010. Prevalent types of cancer treatment
include chemotherapy, surgery, and radiation therapy. An investigation conducted by Ministry of
Health, Labor and Welfare of Japan [17] reported that their percentages are 81%, 72%, and 32%,
respectively (the numbers include combinations of treatment types). National Cancer Institute
also reported that half of the cancer patients receive radiation therapy during their treatment [14].
Radiation therapy is a treatment that uses several beams of ionizing radiation against cancer
tumors, using a property that the beam irradiation has effect of reducing or killing cancer tumors.
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Figure 1: An image of beam intensities for a tumor and normal tissues.
One of the merits of radiation therapy is that patients receive weak damage to the body compared
to surgery, and this can bring high possibilities for continuing a normal daily life.
Intensity-modulated radiotherapy treatment (IMRT) has brought a remarkable flexibility in
dose irradiated from the beams. With the aid of computers and the usage of devices like multi-
collimator, IMRT can control the beam irradiation with higher accuracy than before, and this
leads to the high accuracy of the radiation delivery. The irradiation device can continuously rotate
around a patient who is on a couch and it irradiates the ionizing radiation at certain angles. In
the left figure of Figure 1, the beam is irradiated at the five angles, 0◦, 72◦, 144◦, 216◦ and 288◦.
The right figure of Figure 1 shows that, due to an appropriate adjustment of the beam intensities,
the tumor receives a high dose and at the same time the normal tissues are kept away from the
high dose. The patient, however, can not move during the treatment to increase the irradiation
accuracy. In practice, the number of angles during one treatment is limited to four to nine in order
to lessen a burden on the patient [9].
The computation of IMRT planning involves several optimization aspects, for example, beam
angle optimization (BAO) [3, 7, 10, 28, 12], fluence map optimization (FMO) [2, 24, 26], and
direct aperture optimization (DAO) [25, 27]. BAO chooses the best angles from candidate angles
on constraints like the number of angles available for one treatment, and FMO is an optimization
problem to determine the irradiation intensity for given beam angles. DAO considers the locations
of multi-collimator and beam intensity simultaneously. Chapters 4 and 5 of the handbook [21]
discussed many aspects on IMRT from the viewpoints of optimization.
A difficulty arising in FMO problems, however, is that not only malignant tumors but also
normal tissues near the tumors receive negative effects from the beam irradiation. The oncologists
develop treatment plans for the irradiation areas and the beam intensity to reduce the damage
onto the normal tissues.
A key criterion of the treatment plans is to satisfy dose-volume constraints (DVCs). A DVC is
a radiation-dose constraint on a partial volume of an organ. For example, more than 90% area of
the tumor should receives at least 50 Gy (Gy is the international unit of ionizing radiation dose
per unit mass; 1 Gy = 1 Joule/kg), while the fraction of the normal tissues that receive 25 Gy or
higher should be under 10%. Figure 2 shows an example of dose-volume histograms (DVHs) for a
cancer tumor and normal tissues near the tumor. The blue line is a histograms for a tumor PTV
and the other lines are for Cord, Lt Parotid and Rt Parotid. In Figure 2, the horizontal axis is a
dose volume and the vertical axis is the fraction of the structure. The PTV histogram passes the
point (50 Gy, 90%), and this indicates that the tumor area that receives 50 Gy or more is 90%.
This histogram satisfies a DVC on the tumor which requires that the area that incurs at least 50
Gy takes at least 90% of the tumor (This DVC will be expressed as L0.90PTV = 50 in the notation
2
that will be introduced in Section 2.1).
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Figure 2: An example of dose-volume histograms for a tumor (PTV) and normal tissues (Cord,
Lt Parotid and Rt Parotid).
In general, multiple DVCs can be imposed for one treatment. To find a good treatment
plan that satisfies all the DVCs on tumors and normal tissues, a number of approaches based
on mathematical optimization methods have been proposed. Morrill et al. [18] employed Linear
programming (LP) problems for FMO problems with DVCs. Merrit et al. [16] proposed a successive
LP approach. In determining the beam intensity, a few parts of body receive much large dose,
and such outliers make it very hard to find a feasible solution. Merrit et al. detected these
outliers based on the information of a dual LP problem, and relaxed the dose threshold for the
outliers to higher values. Zhang et al. [30] proposed a two-stage sequential LP approach. Aleman
et al. [1] solved an optimization problem that minimizes a quadratic objective function which
evaluated the deviations from DVCs. They proposed a specific interior-point point method to
solve this quadratic optimization problem. Hamacher and Ku¨der [13] examined a multiple objective
optimization approach . Chu et al. [5] and Olafsson and Wright [20] discussed approaches based on
robust optimization framework with second-order cone programming problems. Romeijn et al. [24]
introduced a concept of C-VaR (conditional value-at-risk) that had been originally developed in
financial engineering. Instead of DVCs, they used constraints that the average dose for a given
fraction part should satisfy a given threshold. As pointed in [29], FMO problems with DVCs
formulated in mathematical optimization problems often have multiple local minimum solutions
and such problems are essentially NP-hard [26].
Among the above methods, an advantage of the C-VaR type constraints of Romeijn et al. [24] is
that any irradiation intensity obtained from their LP problems satisfies all the DVCs. This property
is not clearly mentioned in their paper, and we will verify it later in Lemma 2.2. They solved only
one LP problem, therefore, its computation cost was not expensive. However, the feasible region
of their LP problem was much narrow compared to the region intended by the DVCs. Since LP
problems can be solved by a polynomial-time algorithms while the FMO problems themselves are
NP-hard, we can not completely remove the gap between the C-VaR type constraints and the
DVCs. In particular, the outliers seriously affected the average dose. This approach failed to
find the beam intensities for some test instances of Task Group (TG) 119 report by the American
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Association of Physicists in Medicine (AAPM) [11].
In this paper, we propose a successive LP approach that employs the C-VaR type constraints.
We detect the outliers using LP problems which evaluate the deviation from the DVCs in the
constraints, and remove the outliers successively from the domain of the C-VaR type constraints.
We will show that if the objective value of the successive LP problems becomes non-positive,
the proposed method outputs beam intensities that satisfy all the DVCs. The adjustment of the
outliers by the successive LP problems enables the proposed method to search a wider region than
the approach of Romeijn et al. In addition, the sequence of the objective values of the successive
LP problems are non-increasing. This property implies that we can generate a sequence of the
solutions that approaches to the DVCs. Since our optimization problems are still LP problems,
the computation cost does not increase so much compared to the successive LP approach of Merrit
et al. [16].
We conducted numerical tests to verify the performance of our approach. For test instances
included in TG 119. our approach successfully found beam intensities that satisfied the DVCs
within a few LP iterations. In addition, the solution of our approach satisfied the DVCs more
appropriately than Merrit et al.
The rest of this paper is organized as follow. In Section 2, we first give a more precise definition
and notation on DVCs and briefly discuss the formulations of Merrit at al. and Romeijn et al.
In Section 3, we describe the details on our approach and, in Theorem 3.2, we give a proof of
mathematical properties of our approach that are favorable for the FMO computation. Section 4
reports the numerical results on the TG 119 test instances. In Section 5, we will discuss several
aspects of our approaches and extensions. Finally, we will give a conclusion in Section 6.
2 Preliminaries and Existing Formulation
As notation, we use |S| to denote the cardinality of a set S. We take a nonnegative part of a
number x by denoting (x)+ := max{x, 0}.
2.1 Preliminaries
To apply numerical computation to the IMRT problem in a practical way, the intended organs
(or structures) and the radiation beams are often discretized into voxels (small cuboid units) and
beamlets, respectively. Let S be the set of the structures. For each structure s ∈ S, we use Vs
to denote the voxel set of s. Without loss of generality, we assume |Vs| > 0 throughout of this
paper. In IMRT, the multi-leaf collimators make it possible to treat the radiation beam as a set
of beamlet and control the intensity of each beamlet independently. The set of beamlet is denoted
by B. The area radiated from each beamlet is usually 10 mm × 10 mm, 5 mm × 5 mm, 3 mm ×
3 mm and the number of beamlets |B| is from hundreds to thousands. The order of the number
of voxels is usually 104.
It is often assumed that a dose of each voxel received from the beamlets is a linear function,
therefore, the dose that the ith voxel in the sth structure receives can be expressed in zsi =∑
j∈BDsijxj. Here, xj is the intensity of the jth beamlet. The element Dsij is the (i, j)th element
of a matrix Ds ∈ R
|Vs|×|B|, and the matrix Ds is called a fluence matrix and its element Dsij
expresses the dose that the ith voxel in the sth structure receives from the unit intensity of the jth
beamlet. To compute the fluence matrix, Naqvi et al. [19] utilized the Monte Carlo superposition.
In the material below, we assume that the fluence matrix is given.
In a suitable treatment plan, its corresponding histogram should satisfy the DVCs. Precisely
speaking, a DVC is identified by a structure s and a fractional parameter α ∈ (0, 1). We can
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classify the DVCs into the two types, the upper and lower DVCs;
(upper) The fraction of the voxels in the structure s that receive at least Uαs Gy is at most
α.
(lower) The fraction of the voxels in the structure s that receive at least Lαs Gy is at least
α.
As an example, let us impose three DVCs to a tumor named PTV; L0.9PTV = 50.0, L
0.99
PTV = 46.5
and U0.2PTV = 55.0. In this case, at least 99% of the tumor PTV must receive at least 46.5 Gy.
Furthermore, 90% of PTV should receive a higher dose than 50.0 Gy. At the same time, we should
also avoid extremely strong intensity and this is expressed by the upper constraint of U0.2PTV, that
is, 20% voxels or less of PTV can exceed 55.0 Gy. As shown in this example, the number of DVCs
imposed for one tumor or organ can be larger than one.
In the following discussion, we will use As and As to denote the set of the fractions that are
involved in the lower and upper DVCs of the structure s, respectively. For each α ∈ As, we associate
the upper DVC whose threshold is Uαs Gy. Similar notation is applied to α ∈ As for the lower
DVC with Lαs Gy. In the DVC example above, we have APTV = {0.9, 0.99} and APTV = {0.2}.
In a mathematical form, a single upper DVC can be described as |{i∈Vs|zsi>U
α
s }|
|Vs|
≤ α, and a single
lower DVC as |{i∈Vs|zsi>L
α
s }|
|Vs|
≥ α.
We assume that As ⊂ (0, 1) and As ⊂ (0, 1). For the specific fractional case corresponding to
α = 0 or α = 1, we also denote the upper or lower bounds by Us and Ls, respectively. When these
threshold are used, each voxel in the structure s is required to receive the dose between Ls and
Us.
An FMO problem can now be casted as a mathematical problem to find the beamlet intensities
that satisfy all the DVCs. If we are allowed to use mixed-integer programming problems, one goal
in FMO is to find a solution of the feasible set F defined by
F := {x ∈ R|B| :
∑|B|
j=1Dsijxj = zsi for i = 1, . . . , |Vs|; s = 1, . . . , |S|
Ls ≤ zsi ≤ Us for i = 1, . . . , |Vs|; s = 1, . . . , |S|
zsi ≥ 0 for i = 1, . . . , |Vs|; s = 1, . . . , |S|
zsi ≥ L
α
s b
α
si for i = 1, . . . , |Vs|;α ∈ As; s = 1, . . . , |S|
bαsi ∈ {0, 1} for i = 1, . . . , |Vs|;α ∈ As; s = 1, . . . , |S|∑|Vs|
i=1 b
α
si ≥ α|Vs| for α ∈ As; s = 1, . . . , |S|
zsi ≤ U
α
s +Mb
α
si for i = 1, . . . , |Vs|;α ∈ As; s = 1, . . . , |S|
b
α
si ∈ {0, 1} for i = 1, . . . , |Vs|;α ∈ As; s = 1, . . . , |S|∑|Vs|
i=1 b
α
si ≤ α|Vs| for α ∈ As; s = 1, . . . , |S|
xj ≥ 0 for j = 1, . . . , |B| }.
(1)
In this definition, a scalar M is so-called big-M, a constant number large enough. To express
the fraction of the partial volume, the binary variables bαsi and b
α
si are introduced. We should
remark that a single upper DVC | {i ∈ Vs|zsi > U
α
s } | ≤ α|Vs| is imposed by a combination of
zsi ≤ U
α
s +Mb
α
si, b
α
si ∈ {0, 1} and
∑|Vs|
i=1 b
α
si ≤ α|Vs|. The number of voxels exceeds thousands in
practical situations, so the number of these binary variables are also considerably large. The set
F embraces properties of combinatorial sets and it is not an easy task to find a feasible point of
F exactly. As pointed in [26], such a task is NP-hard.
2.2 A successive linear programming method
In 2002, Merritt et al. [16] employed LP problems to formulate the FMO problem in a mathematical
way and exploited the information obtained from the dual LP problems. Their method is refereed
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as Method-M in the material below. A main idea of Method-M is to solve LPs successively
searching better beamlet intensities. We now briefly introduce Method-M by a simple situation
which involves one tumor structure (s = 1) and one healthy structure (s = 2). We consider hard
DVC thresholds U1 and U2 on the tumor and the healthy structures, respectively, and use a soft
DVC threshold Uα2 such that U
α
2 ≤ U2. A framework of Method-M for this situation is given as
follow, and this framework can be easily extended to general cases of more DVCs.
Algorithm 2.1. [16] (Method-M) A successive LP method for the FMO optimization
1. Set the iteration number k = 0, and set an initial set R0 = ∅. Set a parameter λ > 0 and a
stopping threshold τˆ > 0.
2. Solve the following kth LP to determine the intensity of beamlets x ∈ R|B| and let τk be the
optimal value of this LP.
maximize τ
subject to
|B|∑
j=1
Dsijxj = zsi for i = 1, . . . , |Vs|; s = 1, 2
τ ≤ z1i ≤ U1 for i = 1, . . . , |V1|
z2i ≤ U2 i ∈ Rk
z2i ≤ U
α
2 i /∈ Rk
zsi ≥ 0 for i = 1, . . . , |Vs|; s = 1, 2
xj ≥ 0 for j = 1, . . . , |B|.
3. If τk > τˆ , output the optimal solution of the kth LP and stop.
4. Update Rk with the rule Rk+1 = Rk ∪ {i ∈ V2 | y
∗
i > λ}, where y
∗
i is the dual variable
corresponding to the constraint z2i ≤ U
α
2 in the kth LP.
5. Increment k and return to Step 2.
In the kth LP, each voxel in the tumor structure (s = 1) receives the dose at least τ , therefore,
the aim in the kth LP is to maximize τ so that the voxels in the tumor receives as high dose as
possible.
The usage of the hot-spot set Rk characterizes Method-M. Though it is preferable that each
voxel in the healthy structure (i ∈ V2) should be imposed by a low limit z2i ≤ U
α
2 , such a constraint
is too restrictive to satisfy. Therefore, Merritt et al. relaxed this constraint so that a small set
Rk ⊂ V2 can be exposed to higher dose than U2 (Note that U2 ≥ U
α
2 ). These voxels, regarded as
outliers, are determined using the information from the dual LP problem in Step 4. The updated
hot-spot set Rk+1 is composed of the voxels for which the lower limit z2i ≤ U
α
2 is too restrictive.
In contrast, a disadvantage of this method is that it does not take the fractional parameter
α of tumor into consideration. The constraints in the LP problem involve all the voxels in the
structures, and they are much stronger than the DVCs. Since the feasible region has a tendency
to become very narrow, this method may fail to find favorable beamlet intensities for DVCs.
2.3 An Approach Based on C-VaR type Constraints
Romeijn et al. [24, 23] also utilized LP problems to determine the beamlet intensities, but their
approach brought a different perspective. Their method is refereed as Method-R in this paper. The
6
Figure 3: A comparison between DVC and C-VaR type constraint
key step of Method-R is to replace the DVCs with C-VaR type constraints in the LP problem, and
only one LP problem is solved. C-VaR stands for conditional value at risk, and it was originally
introduced by Rockafellar [22] in a context of economics. In economics, there is a demand for
estimating the expected value of the loss that exceeds a certain level called Value at Risk (VaR).
In particular, C-VaR has high affinity with a fraction.
For a random variable X and level α, the original definition of C-VaR computes an average of
VaR using an integral as follow:
CVaR1−α(X) :=
1
α
∫ α
0
VaR1−τ (X)dτ.
Here, we do not discuss a precise definition of VaR, since an equivalent but more convenient
form of C-VaR is available:
CVaRα(X) := min
C∈R
{
C +
1
1− α
E[(X − C)+]
}
. (2)
A key step of Method-R is to replace a single upper DVC |{i ∈ Vs|zsi > U
α
s }| ≤ α|Vs| with a C-VaR
type inequality
min
C∈R

C +
1
α|Vs|
|Vs|∑
i=1
(zsi − C)
+

 ≤ Uαs .
This inequality is equivalent to find ζ
α
s ∈ R which satisfies
ζ
α
s +
1
α|Vs|
|Vs|∑
i=1
(zsi − ζ
α
s )
+ ≤ Uαs . (3)
The upper DVC imposes that the number of voxels that receive Uαs or more is bounded by
α|Vs|. In contrast, the upper C-VaR type constraint (3) requires that the mean dose of the α|Vs|
highest voxels be under Uαs . Here, we use Figure 3 to compare DVC and the C-VaR type constraint
in the DVH style. The upper DVC on Uαs = 0.05 requires the leftmost point of blue region be less
than Uαs . In contrast, the upper C-VaR corresponding to this DVC requires that the mean of blue
region be less than Uαs . Therefore, when U
α
s lies between the leftmost point and the mean, there
is a difference between the DVC and the C-VaR type constraint. In Chapter 3, we will observe
this in detail.
We can develop the inequality (3) in another way. For simplicity, we assume that α|Vs| is an
integer number. Let us use Sk(z) for an integer k and z ∈ R
n to denote the sum of the k largest
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elements of z. In [4, Example 9.10], it is shown that Sk(z) ≤ t is equivalent to a condition that
there exists ζ, t1, t2, . . . , tn ∈ R such that


t ≥ kζ + (t1 + t2 + · · · + tn)
t1, t2, . . . , tn ≥ 0
t1 − z1 + ζ ≥ 0, t2 − z2 + ζ ≥ 0, tn − zn + ζ ≥ 0.
(4)
Since the mean dose of the α|Vs| highest voxels should be less than U
α
s , we have
Sα|Vs|(zs)
α|Vs|
≤ Uαs .
Here, zs is the vector that collects the doses in the structure s, zs := (zs1, . . . , zs|Vs|)
T ∈ R|Vs|.
Applying (4) with k = α|Vs| and t = α|Vs| · U
α
s , we can show that
Sα|Vs|(zs)
α|Vs|
≤ Uαs if and only if
there exists ζ
α
s ∈ R that satisfies (3).
By introducing the concept of C-VaR to the IMRT optimization, Romeijn et al. [24] proposed
the following LP problem:
minimize
|S|∑
s=1
|Vs|∑
i=1
Fs(zsi) (5a)
subject to
|B|∑
j=1
Dsijxj = zsi i = 1, . . . , |Vs|; s = 1, . . . , |S| (5b)
Ls ≤ zsi ≤ Us i = 1, . . . , |Vs|; s = 1, . . . , |S| (5c)
ζα
s
−
1
(1− α)|Vs|
|Vs|∑
i=1
(ζα
s
− zsi)
+ ≥ Lαs α ∈ As; s = 1, . . . , |S| (5d)
ζ
α
s +
1
α|Vs|
vs∑
i=1
(zsi − ζ
α
s )
+ ≤ Uαs α ∈ As; s = 1, . . . , |S| (5e)
xj ≥ 0 j = 1, . . . , |B| (5f)
zsi ≥ 0 i = 1, . . . , |Vs|; s = 1, . . . , |S| (5g)
ζα
s
, ζ
α
s : free variable (5h)
Here, the decision variables are the beamlet intensities x1, . . . , x|B|. To implement the C-VaR type
constraints, intermediate variables ζα
s
and ζ
α
s are employed.
They used piecewise a linear function Fs for the objective function in order to express an
deviation from their desired situation, and this objective function remained (5) as an LP problem.
Aleman et al. [1] examined quadratic penalty functions for the objective function to incorporate the
deviation, and they applied interior-point methods to solve the resultant quadratic optimization
problem.
The validity of C-VaR type constraints in (5) can be guaranteed by the following lemma.
Though this claim was partially implied in [23], we give it in an explicit way.
Lemma 2.2. Any feasible solution of (5) fulfills all the DVCs.
Proof: From the constraint (5c), it is clear that the hard DVCs (Ls ≤ zsi ≤ Us) are satisfied.
We now assume that a single upper DVC | {i ∈ Vs|zsi > U
α
s } | ≤ α|Vs| is violated, and we will
derive a contradiction. From this assumption, the number of voxels such that zsi > U
α
s is greater
than α|Vs|. Since U
α
s ≥ ζ
α
s from (5e), it holds that zsi > ζ
α
s when zsi > U
α
s . There exists at least
one i such that zsi > ζ
α
s , since | {i ∈ Vs|zsi > U
α
s } | > α|Vs| ≥ 0 from our assumption, hence, we
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have (zsi − ζ
α
s )
+ = zsi − ζ
α
s > U
α
s − ζ
α
s for such i. It leads to
ζ
α
s +
1
α|Vs|
|Vs|∑
i=1
(zsi − ζ
α
s )
+ > ζ
α
s +
1
α|Vs|
(α|Vs|) (U
α
s − ζ
α
s ) = U
α
s
and this contradicts to (5e). Hence, any feasible solution of (5) does not violate the upper DVC.
A similar discussion can be applied to the lower DVCs (5d).
This lemma indicates an advantage of the LP model (5) that if a feasible solution is found in (5),
it should fulfill all the DVCs. A negative side is that this approach may fail to find solutions that
exist in the gap between the DVCs and the C-VaR type constraints (The converse of Lemma 2.2
does not hold in general). This approach searches only narrower feasible region than the original
DVCs, and this aspect motivated us to develop a successive method that extends the feasible
region from the C-VaR type constraints.
3 Successive Linear Programming Approach with C-VaR type
Constraints
A main difficulty in handling the DVCs is that the DVCs involve the fraction α, hence finding a
feasible solution is already a demanding task. Method-M utilized the hot-spot to remove some
outliers from the strict constraints, and Method-R introduced the C-VaR type constraints to
replace the original DVCs. A common problem arising from the two methods was that their
search regions were not wide enough to cover the region shaped by the DVCs. Hence, the two
methods sometimes fail to find a feasible solution, even when the original feasible set has enough
space.
In particular, we observed from preliminary numerical tests that the C-VaR type constraints
are sensitive to outliers in the sense that the voxels that have extremely high or low doses affect
the constraints of (5) seriously.
ave
gap
Figure 4: A DVH in which a few voxels receive extremely high doses
To illuminate such a phenomenon, we compare Figures 3 and 4 that partially illustrate different
solutions of an FMO problem in the style of DVH. The two DVHs are almost same, but Figure 4
has a few voxels that receive extremely high doses. Their means of the blue region are quite
different, and it indicates that the satisfiability of (5e) strongly depends on the voxels that have
the highest doses. Such voxels should be handled carefully as outliers.
We propose a method that combines the successive update of outliers and the concept of the
C-VaR type constraints. In the proposed method, we first solve an LP problem by relaxing the
C-VaR constraints so that this LP problem always has a feasible point. From the optimal solution
of this LP problem, we extract the outliers and transfer them from the domain of the C-VaR type
9
constraints (5e) to the sets of outliers. Using the new sets, we build a next LP problem. We repeat
the updates of outliers until we obtain a feasible solution that satisfies the original DVCs. This
new method has several favorable properties, and we will discuss them in Theorem 3.2.
0.05
Figure 5: Effect of the exclusion of R
The comparison between an original DVC, its corresponding C-VaR type constraints and the
constraint in the proposed method is summarized as an illustrative example of Figure 5. We denote
the left endpoint of the blue and red areas by ηa. We also use ηb and ηc to denote the mean dose
of the red area and that of blue and red areas, respectively. The value on this DVH at ηa is 0.05,
therefore this solution satisfies an DVC of U0.05s if and only if ηa ≤ U
0.05
s . Similarly, ηc ≤ U
0.05
s
if and only if the solution satisfies the C-VaR type constraint for Uαs . From the discussion in the
previous paragraphs, if U0.05s in the interval ηa < U
0.05
s < ηc, this solution is a feasible solution
of the FMO problem, even though the approach based on the C-VaR type constraints fails to
recognize this solution as a feasible solution.
We consider an effect of excluding voxels that have highest doses by defining them as a set of
outliers R. We evaluate the left-hand side of the C-VaR type constraint using only the rest of the
voxels. In Figure 5, this corresponds to the removal of the blue regions, therefore, the left-hand
side of the C-VaR type constraint is shifted from ηc to ηb. If U
0.05
s is in the interval ηb < U
0.05
s < ηc,
this new approach can detect this solution is feasible. This is the key idea of our approach.
The framework of the proposed method is summarized in Algorithm 3.1. In the kth LP problem
of Step 2, we use R
k,α
s and R
k,α
s to denote the sets of outliers with respect to the thresholds α ∈ As
and α ∈ As, respectively. In addition, the objective function t is introduced to measure the
deviation from the DVCs. The positive constants P s, P s, P
α
s and P
α
s are embedded to control the
relaxation of the DVCs.
Algorithm 3.1. A successive updates of outliers with C-VaR type constraints for FMO problems
1. Set the iteration counter k = 1 and the initial sets of outliers R
1,α
s = ∅ for α ∈ As, s ∈ S
and R1,αs = ∅ for α ∈ As, s ∈ S. Choose positive constants P s and P s for s ∈ S, P
α
s for
α ∈ As, s ∈ S, and P
α
s for α ∈ As, s ∈ S.
2. Solve the following kth LP. Let t(k) be the optimal value of this LP problem, and x
(k)
j and
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z
(k)
si the obtained solution.
min t (6a)
s.t.
|B|∑
j=1
Dsijxj = zsi i ∈ Vs; s ∈ S (6b)
zsi ≤ Us + P st i ∈ Vs; s ∈ S (6c)
zsi ≥ Ls − P st i ∈ Vs; s ∈ S (6d)
ζα
s
−
1
(1− α)|Vs| − |R
k,α
s |
|Vs|∑
i=1
i/∈Rk,αs
(ζα
s
− zsi)
+ ≥ Lαs − P
α
s t α ∈ As; s ∈ S (6e)
ζ
α
s +
1
α|Vs| − |R
k,α
s |
|Vs|∑
i=1,i/∈R
k,α
s
(zsi − ζ
α
s )
+ ≤ Uαs + P
α
s t α ∈ As; s ∈ S (6f)
xj ≥ 0 j ∈ B (6g)
zsi ≥ 0 i ∈ Vs; s ∈ S (6h)
ζ
α
s : free variable α ∈ As; s ∈ S (6i)
ζα
s
: free variable α ∈ As; s ∈ S (6j)
t : free variable
3. If t(k) ≤ 0, output x(k) as the solution and stop.
4. Update the sets of outliers by the rules
R
k+1,α
s :=
{
i ∈ Vs : z
(k)
si > U
α
s + P
α
s t
(k)
}
, Rk+1,αs :=
{
i ∈ Vs : z
(k)
si < L
α
s − P
α
s t
(k)
}
.
Increment k and return to Step 2.
The proposed method has the following suitable properties.
Theorem 3.2. We assume that the feasible region F of the FMO problem (1) is not empty. Then,
for the LP problems solved in Algorithm 3.1, it holds that
(a) For any k ≥ 1, the kth LP problem (6) has an optimal solution.
(b) If t(k) ≤ 0, the output solution x(k) satisfies all the DVCs (that is, x(k) ∈ F).
(c) The sequence {t(k)} is monotone non-increasing.
Part (a) indicates that the solution x(k) is well-defined through the execution of Algorithm 3.1.
Part (b) gives a validity for the stopping criterion t(k) ≤ 0 in Step 3. Finally, we can infer from
Part (c) that the sequence {x(k)} has a tendency to approach to the set that satisfy all the DVCs.
We remark that the solution obtained from Method-R corresponds to x(1) of Algorithm 3.1
with the parameters P s = P s = P
α
s = P
α
s = 0 for all s and α. From Part(c), therefore, the
proposed method is more flexible than Method-R.
Proof: For Part(a), we first consider the case k = 1 and discuss k ≥ 2 by induction. At the
beginning of k = 1, R1,αs and R
1,α
s are empty sets. The denominators, therefore, in (6e) and (6f)
are not zero, as |Vs| > 0 without loss of generality and 0 < α < 1. The initial LP problem (k = 1)
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is well-defined, and we can give a feasible solution explicitly by xj = 0 (j = 1, . . . , |B|), zsi = 0
(i = 1, . . . , |Vs|, s = 1, . . . , |S|), ζ
α
s = 0 (α ∈ As, s = 1, . . . , |S|), ζ
α
s
= 0 (α ∈ As, s = 1, . . . , |S|) and
t = mins=1,...,|S|
{
Ls/P s,minα∈Aαs {L
α
s /P
α
s , }
}
. Therefore, we know that
ζ
α
s +
1
α|Vs| − |R
k,α
s |
|Vs|∑
i=1,i/∈R
k,α
s
(zsi − ζ
α
s )
+ = ζ
α
s +
1
α|Vs|
|Vs|∑
i=1
(zsi − ζ
α
s )
+
≥ ζ
α
s +
1
|Vs|
|Vs|∑
i=1
(zsi − ζ
α
s )
+ =
1
|Vs|
|Vs|∑
i=1
{
ζ
α
s + (zsi − ζ
α
s )
+
}
≥ 0.
The last inequality holds from an inequality p+(q−p)+ ≥ 0 for any p ∈ R and q ≥ 0. From (6c) and
(6f), the objective function t has a lower bound t ≥ max
{
maxs=1,...,S
{
−Us/P s
}
,maxα∈Aαs
{
−Uαs /P
α
s ,
}}
.
From the duality theorem of linear programming [6, etc], the initial LP problem has an optimal
value t(1).
Next, we assume that the kth LP has its optimal value t(k) and optimal solution x
(k)
i and z
(k)
si ,
and we examine the (k + 1)th LP. If the number of voxels in Vs such that z
(k)
si > U
α
s + P
α
s t
(k) and
i /∈ R
k,α
s were no less than α|Vs| −R
k,α
s , we would have
ζ
α
s +
1
α|Vs| − |R
k,α
s |
|Vs|∑
i=1,i/∈R
k,α
s
(z
(k)
si − ζ
α
s )
+ > ζ
α
s +
1
α|Vs| − |R
k,α
s |
(α|Vs| − |R
k,α
s |)(U
α
s + P
α
s t
(k) − ζ
α
s )
= Uαs + P
α
s t
(k),
but this contradicts (6f). Hence, the number of voxels that will be newly added to R
k+1,α
s is less
than α|Vs| −R
k,α
s , and this leads to
|R
k+1,α
s | < (α|Vs| −R
k,α
s ) +R
k,α
s = α|Vs|. (7)
For the lower DVCs, we also obtain |Rk+1,αs | < (1 − α)|Vs|. Therefore, the denominators in (6f)
and (6e) are not zero again, and we can use the same discussion as the initial LP problem to derive
that the (k + 1)th LP has an optimal value t(k+1). By induction, for any k ≥ 1, the kth LP has
its optimal value t(k).
For Part (b), from the definition of R
k+1,α
s =
{
i ∈ Vs : z
(k)
si > U
α
s + P
α
s t
(k)
}
, the non-positivity
of t(k) indicates that {i ∈ Vs : z
(k)
si > U
α
s } ⊂ R
k+1,α
s . Using the upper bound of the size of R
k+1,α
s
obtained in (7), we have |{i ∈ Vs : z
(k)
si > U
α
s }| ≤ |R
k+1,α
s | ≤ α|Vs| and this means the solution of
kth LP problem satisfies the corresponding upper DVCs. We can also show that the solution with
non-positive t(k) satisfies the lower DVCs in a similar way.
Finally, in order to verify the inequality t(k+1) ≤ t(k) of Part (c), we give a feasible solution
of the (k + 1)th LP problem such that t = t(k). We set t = t(k), xj = x
(k)
j , zsi = z
(k)
si , ζ
α
s
=
Lαs − P
α
s t
(k) and ζ
α
s = U
α
s + P
α
s t
(k). Since these values are derived from the kth LP problem, it
is easy to check that these values satisfy the constraints of (6) except (6f) and (6e). In (6f), the
summation
∑|Vs|
i=1,i/∈R
k+1,α
s
(zsi − ζ
α
s )
+ is zero due to R
k+1,α
s =
{
i ∈ Vs : z
(k)
si > U
α
s + P
α
s t
(k)
}
and
ζ
α
s = U
α
s +P
α
s t
(k). Therefore, the left-hand side of (6f) reduces to Uαs +P
α
s t
(k) and this is same as
the right-hand side. Again, we apply a similar step to (6e).
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4 Numerical Experiment
We used a dataset of the American Association of Physicists in Medicine (AAPM) Task Group
(TG) 119 report [11]. The dataset includes four mock test cases; a C-shape case, a mock prostate
case, a mock head/neck case and a multi target case. Table 1 is a summary of the dataset. For
these four cases, the table shows the number of beamlet, the organ names, the number of voxels
in the organs and the DVCs.
We compare the proposed method with Method-M (the successive LP method of Merrit et
al. [16]) to demonstrate the performance of the proposed method. We did not include Method-R
(the C-VaR method of Romeijn et al. [24]) for the comparison, since we found from preliminary
experiments that the LP problems in the Method-R for all of the four test cases in AAPM TG119
were infeasible.
The dataset of AAPM TG119 is provided as 3D image format called DICOM. Using the
CERR software 4.0 Beta 2 [8] and MATLAB 2013b, we transformed the DICOM files into the LP
problems (6). We ran CERR with its default settings. Then, we called CPLEX 12.6.0 to solve the
generated LP problems. Finally, we again utilized CERR to visualize the solutions and checked
whether the obtained solutions satisfied the DVCs. We also used CERR to prepare a manageable
dataset from the TG119 dataset. The number of voxels in the PTV organ of the mock head/neck
case was more than 50,000 and this was too large to solve (6) on 16 GB memory space of our
computing environment. For only this case, therefore, we chose 10,000 voxels randomly from the
50,000 voxels. We examined a number of this random selection and we observed this operation
did not affect the numerical results so much. The computing environment was Windows 8 run on
an Intel Core i7-4790 (3.6 GHz, 4 cores) and 16 GB of memory space.
A desirable stopping criterion of the proposed method is t(k) ≤ 0, since Theorem 3.2 showed
that the output solution x(k) satisfies all the DVCs when t(k) ≤ 0. Due to the intrinsic difficulty
arising from combinatorial aspects of the DVCs, the number of iterations to attain t(k) ≤ 0 would
be prohibitive. As a practical stopping criterion, we stop the proposed method when the iteration
count k reaches 5 and output x(5).
For the numerical computation of Method-M (Algorithm 2.1), we should describe configurations
more specifically. The description for Method-M in Section 2.2 discussed only one tumor structure
and only one healthy structure. To compute multiple tumors for Multi Target case, we associated
τs for each tumor structure, and we maximized
∑
τs over all of the tumor structure. Next, we set
the parameter λ = 10−6. Finally, we stopped Method-M when the set R became infeasible on a
DVC; more precisely, when |Rαs | exceeded α|Vs|. When the infeasibility was detected at the kth
iteration, the solution of Method-M was extracted from the solution of (k − 1)th iteration.
For the execution of the proposed method, we need to specify values for positive constants
P s, P s, P
α
s , P
α
s . We assigned 1 to these constants for all the cases except the C-shape case. For
the C-shape case, we will explain more details later.
4.1 Results
Table 2 reports whether the obtained solutions satisfies DVCs or not. In addition, we also provide
the DVH figures in Figures 6, 7, 8, and 9. In these figures, the solid lines and the broken lines
indicate the results of the proposed method and Method-M, respectively, and different colors are
used to clarify the organs.
In Table 2, the column “Proposed” shows the evaluation results of the solution obtained by the
proposed method in the viewpoint of DVCs. For example, the value 50.3 in the row L0.95Outer Target
indicates that 95% of Outer Target receives at least 50.3 Gy. Therefore, this solution satisfies
L0.95Outer Target = 50.0 and this is indicated by “Pass.” The failure of the solutions are indicated by
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Table 1: A summary of the dataset for numerical comparison
C-shape (The number of beamlets is 414)
organ/tumor The number of voxels DVCs
Outer Target 17522 L0.95Outer Target = 50
U0.1Outer Target = 55
Core 3087 U0.1Core = 25
Mock Head/Neck (The number of beamlets is 619)
organ/tumor The number of voxels DVCs
PTV 10000 L0.99PTV = 46.5
L0.9PTV = 50.0
U0.2PTV = 55
Cord 1333 UCord = 40
Lt Parotid 525 U0.5Lt Parotid = 20
Rt Parotid 740 U0.5Rt Parotid = 20
Mock Prostate (The number of beamlets is 241)
organ/tumor The number voxels DVCs
ProstatePTV 8591 L0.95ProstatePTV = 75.6
U0.05ProstatePTV = 83
Bladder 5207 U0.30Bladder = 70
U0.10Bladder = 75
Rectum 1830 U0.30Rectum = 70
U0.10Rectum = 75
Multi Target (The number of beamlets is 601)
organ/tumor The number of voxels DVCs
Center 5143 L0.99Center = 50
U0.1Center = 53
Superior 5549 L0.99Superior = 25
U0.1Superior = 35
Inferior 5529 L0.99Inferior = 12.5
U0.1Inferior = 25
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“Failed” in the table. In the same way, the column “Method-M” shows the result of Method-M.
The table also reports the numbers of LP problems solved in each test case. The number of the
parenthesis in the “Proposed” column means that the number of LP problems for the proposed
method to acquire a feasible solution. In C-shape, for example, the proposed method obtained a
feasible solution by the third LP problem (t(3) ≤ 0), and improved the solution with the successive
two LP problems. (In the Multi Target case, we used (−) to indicate that we failed to obtain a
non-negative optimal value.)
From the result of Table 2, we observe for the C-Shape case that the solution of the proposed
method satisfies all DVCs. Method-M failed in the DVC L0.95Outer Target = 50.0. We also see that the
green dashed line passes the point (50, 0.5) in Figure 6. This indicates that in the solution of the
Method-M, a half of the voxels in OuterTarget receives less than 50Gy. We can further acquire
similar observations on the Head/Neck case and the Prostate case.
For the Multi Target case, however, Table 2 shows that the solution of the proposed method
fails to satisfy all DVCs. This means that the solution is far from a favorable solution. In addition,
the shapes of the proposed method in Figure 9 are gradual slopes. In contrast, Method-M has a
narrow width and outputs a better solution than the proposed method for only the Multi Target
case.
Since the proposed method outputs solutions that matches the DVCs more adequately than
Method-M for three problems out of the four cases, the proposed method has a tendency to output
favorable solutions than Method-M. Furthermore, Table 2 shows that the numbers of iterations in
the proposed method were at most 5. This implies that the proposed is better than Method-M
from the viewpoint of computation cost.
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Figure 6: DVH of C-Shape case
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Table 2: Numerical results for the four test cases
C-Shape
organ/tumor DVCs Proposed Method-M
Outer Target L0.95Outer Target = 50.0 50.3 (Pass) 45.7 (Fail)
U0.10Outer Target = 55.0 54.3 (Pass) 53.6 (Pass)
Core U0.10Core = 25.0 22.0 (Pass) 25.0 (Pass)
the number of iterations 5(3) 14
Mock Head/Neck
organ/tumor DVCs Proposed Method-M
PTV L0.99PTV = 46.5 47.6 (Pass) 38.4 (Fail)
L0.90PTV = 50.0 51.2 (Pass) 40.5 (Fail)
U0.20PTV = 55.0 53.5 (Pass) 51.2 (Pass)
Core UCore = 40.0 39.1 (Pass) 41.3 (Fail)
Lt Parotid U0.50Lt Parotid = 20.0 17.5 (Pass) 20.4 (Fail)
Rt Parotid U0.50Rt Parotid = 20.0 17.5 (Pass) 16.4 (Pass)
the number of iterations 5(3) 27
Prostate
organ/tumor DVCs Proposed Method-M
Prostate PTV L0.95Prostate PTV = 75.6 78.1 (Pass) 74.7 (Fail)
U0.05Prostate PTV = 83.0 82.3 (Pass) 82.2 (Pass)
Bladder U0.30Bladder = 70.0 48.8 (Pass) 48.7 (Pass)
U0.10Bladder = 75.0 72.5 (Pass) 64.5 (Pass)
Rectum U0.30Rectum = 70.0 68.1 (Pass) 70.2 (Pass)
U0.10Rectum = 75.0 74.3 (Pass) 74.8 (Pass)
the number of iterations 5(2) 22
Multi Target
organ/tumor DVCs Proposed Method-M
Center L0.99Center = 50.0 48.2 (Fail) 43.5 (Fail)
U0.10Center = 53.0 54.6 (Fail) 52.1 (Pass)
Inferior L0.99Inferior = 12.5 10.8 (Fail) 21.7 (Pass)
U0.10Inferior = 25.0 26.6 (Fail) 24.9 (Pass)
Superior L0.99Superior = 25.0 23.3 (Fail) 33.3 (Pass)
U0.10Superior = 35.0 36.5 (Fail) 34.9 (Pass)
the number of iterations 5(-) 15
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Figure 7: DVH of Head/Neck case
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5 Discussions
In this paper we propose a new iterative algorithm for the FMO problems. Here, we discuss several
aspects of the proposed method.
The result on Multi Target
The results on the Multi Target case imply an weakness of the proposed method. We have two
reasons that the proposed method did not work properly for this test case. First, the concept of
our method is to get a better solution by adjusting unsatisfied inequalities in the LP problem (6).
Hence, the solution in a next iteration often improves the satisfiability of the unsatisfied inequal-
ities. At the same time, however, this may bring a negative effect on the inequalities that are
already satisfied. In particular, if there are hard constraints (with Ls and Us) and soft constraints
(with Lαs and U
α
s ) together in one problem, the soft constraints are influenced by the hard con-
straints and they sometime become infeasible even when there are feasible solutions that fulfill
these soft constraints. Second, Ezzel et al. [11] pointed out that the Multi Target case is a difficult
test case. They confirmed from statistics that for cases like the Multi Target case, even treatment
planners often generate a solution that do not satisfy DVCs. For such cases, we should employ a
different criterion instead of pursuing DVCs.
Parameters for Method-M
There would be a possibility that a careful selection on the parameters for Method-M might improve
the quality of the solution or the running time. In the numerical experiments, we examined
Method-M changing the parameters and we reported the best results of Method-M from the
different parameters, so further improvements only by the parameter selection are not so promising.
For Method-M, a reduction of the computation time is also a daunting task. The test cases
we used have a few DVC. To solve one LP problem, the proposed method consumed 2-3 times
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computation time of Method-M. However, the proposed method acquired a feasible solution in two
or three iterations. To compete the proposed method, therefore, Method-M should complete its
algorithm with at most ten iterations, but Method-M required at least 14 iterations as shown in
Table 2. We remark that the number of intermediate variables in the LP problems of the proposed
method depends on the number of DVCs, while that of Method-M is independent from the number
of DVCs. Therefore, Method-M may perform well in a test case with a large number of DVCs.
An extension of our approach for precise volumes
Another issue from a different viewpoint is the volume of each voxel. In this paper, we assumed
that an organ was divided into voxels of the same rectangular shape, thus all the voxels had
the same volume. However, voxels at the boundary of an actual structure may partially contain
exterior of the structure. Therefore, there may be a difference between the total volume of voxels
in the structure and the actual volume, and our approach would output a solution with serious
deviations.
Our approach can be extended to handle the precise volume of each voxel by the steps below.
For the ith voxel of the structure s, csi is used to denote the volume of a part of s that is covered
by the ith voxel, in other words, csi is the volume of the intersection of s and the ith voxel. Then,
a constant value Cs :=
∑vs
i=1 csi denotes the actual volume of s. We also define a new set for
outliers C
k,α
s :=
∑
i∈R
k,α
s
csi for an upper DVC. In addition, C
k,α
s is introduced for an lower DVC
We replace the kth LP problem in Algorithm 3.1 with the following LP problem:
minimize t (8a)
subject to
Nb∑
j=1
Dsijxj = zsi i ∈ Vs; s ∈ S (8b)
Ls − P st ≤ zsi ≤ Us + P st i ∈ Vs; s ∈ S (8c)
ζα
s
−
1
(1− α)Cs − C
α
ks
∑
i/∈Rk,αs
csi(ζ
α
s
− zsi)
+ ≥ Lαs − P
α
s t α ∈ As; s ∈ S (8d)
ζ
α
s +
1
αCs − C
k,α
s
∑
i/∈R
k,α
s
csi(zsi − ζ
α
s )
+ ≤ Uαs + P
α
s t α ∈ As; s ∈ S (8e)
xj ≥ 0 j ∈ B (8f)
zsi ≥ 0 i ∈ Vs; s ∈ S (8g)
ζα
s
, ζ
α
s , t : free variables (8h)
A main difference between the original proposed method and this extended method lies in (6e)
and (8d). In the original proposed method, we use the number of voxels to represent fractional
volume of a structure. However, in the extended method, we use their actual volumes of voxels.
Therefore, we include csi in the summation of (8d). This LP problem satisfies the same property
as Theorem 3.2. In particular, we can find a solution that satisfies all the DVCs when the optimal
value t(k) of the kth LP problem is non-positive. Therefore, we can naturally extend the proposed
method to handle the actual volumes.
6 Conclusion and Future Directions
In this paper, we proposed a new method for FMO problems using the C-VaR type constraints of
Romeijn et al. and the outliers of Merrit et al. The proposed method has favorable mathematical
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properties as discussed in Theorem 3.2. In particular, when the optimal value of the LP problems
is non-positive, its optimal solution satisfies all the DVCs. From the numerical experiments, we
verified that the proposed method was effective for the mock case. Particularly, the proposed
method found feasible solutions for the test cases whose feasibilities were not detected by the LP
problems of Romeijn et al. Furthermore, our approach obtained these feasible solutions within a
shorter computation time than the approach of Merrit et al.
Further studies should include the removal of the two weaknesses in the proposed method. The
first one is to get a better solution for the Multi-Target case and similar cases. Though these cases
are very hard as discussed in Section 5, deep investigation the effect of the parameters involved
in the LP problems could improve the situation. In particular, we need a discussion on adaptive
selections of Pαs and P
α
s . The other issue is a strong dependence of the size of LP problems on the
number of DVCs. The size of the LP problems in the proposed method grows rapidly, when the
number of DVCs increases. As a result, the size of solvable FMO problems are limited. We should
reduce the number of variables involved in the LP problems by detecting redundant variables or
inactive constraints.
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